Published in Ann Oncol on January 01, 1990
Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management. J Ovarian Res (2013) 0.75
Impact of cancer treatment guidelines. Ann Oncol (1991) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet (2003) 8.88
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care (2001) 3.67
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Stopping a trial early in oncology: for patients or for industry? Ann Oncol (2008) 3.06
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64
ASA Physical Status and age predict morbidity after three surgical procedures. Ann Surg (1994) 2.52
Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens. J Clin Oncol (2002) 2.00
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis (2009) 1.95
Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med (2011) 1.75
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med (2001) 1.73
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer (2006) 1.70
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS (1998) 1.70
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol (2004) 1.62
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62
Does a drug do better when it is new? Ann Oncol (2002) 1.61
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med (2005) 1.59
Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.58
Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant (1999) 1.57
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med (2013) 1.55
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst (2010) 1.55
Differential diagnosis and management of focal ground-glass opacities. Eur Respir J (2008) 1.54
Drug supply in the aftermath of the 1988 Armenian earthquake. Lancet (1990) 1.53
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care units. Crit Care Med (1998) 1.50
The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up. Arch Intern Med (1999) 1.48
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer (2006) 1.46
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Ann Oncol (2005) 1.45
Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer. Int J Gynecol Cancer (2007) 1.44
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Ann Oncol (1994) 1.43
Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.39
Survey on the treatment of non-small-cell lung cancer in Italy. Ann Oncol (2000) 1.38
Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer (1994) 1.36
Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev (2004) 1.34
Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J Clin Oncol (2003) 1.33
Effects of new smoking regulations in Italy. Ann Oncol (2005) 1.32
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective. Diabet Med (2013) 1.30
A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol (1993) 1.30
Impact of different customization strategies in the performance of a general severity score. Crit Care Med (1997) 1.30
Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol (1999) 1.27
One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model. J Epidemiol Biostat (2000) 1.26
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence. Br J Cancer (2002) 1.24
Etoposide (VP-16-213). Current status of an active anticancer drug. N Engl J Med (1985) 1.23
Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol (1997) 1.21
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med (2008) 1.20
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer (2007) 1.20
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol (1997) 1.19
First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence. Br J Cancer (1998) 1.19
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity. J Med Ethics (2008) 1.18
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer (2003) 1.18
Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. Eur J Cancer (2006) 1.17
The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes. Diabetes Care (2001) 1.17
Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? Ann Oncol (2013) 1.16
Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat (2001) 1.15
Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol (2009) 1.14
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res (2001) 1.13
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol (1995) 1.12
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients. Br J Cancer (2012) 1.11
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med (2013) 1.10
Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med (1998) 1.10
Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer (2000) 1.09
An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol (1998) 1.09
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) (2007) 1.09
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health (1991) 1.07